First patient recruited into a trial of the BeGraft Plus as a bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.
BIO4AMB Trial Results Demonstrate BIOTRONIK’s 4 French Portfolio to Be as Safe and Effective as 6-French Devices While Avoiding Additional Need of a Vascular Closure Device
Primary endpoint of slowed coronary plaque progression reported to have been met with VASCEPA
Significant coronary plaque regression of low attenuation plaque (LAP) reported with VASCEPA provides further insight to potential mechanisms of action
